For decades, patients being treated for drug-resistant tuberculosis have had to endure a gruelling regimen of daily injections and a cocktail of drugs with severe side effects.

New tests recommended by the WHO can address TB cases with no or few symptoms more quickly and improve access to life-saving treatment.

Tuberculosis can recur through relapse or new drug-resistant strains, often triggered by incomplete treatment, a weakened ...

On World TB Day, the World Health Organization (WHO) is urging countries to accelerate action to end tuberculosis (TB) and ...

Shorter duration, fully oral treatment regimens for tuberculosis (TB) are now recommended for most adults and children. Updated joint guidelines from the American Thoracic Society, the CDC, European ...

In the vaccine space, the Gates Medical Research Institute (Gates MRI) is running a Phase III trial of the M72/AS01E vaccine ...

Tuberculosis (TB) is a major unrecognized cause of deadly sepsis among people with HIV in Africa, a sweeping new study reveals. Beginning treatment for TB immediately – even before sepsis patients are ...

This World Tuberculosis (TB) Day, Médecins Sans Frontières (MSF) urges governments and international donors to bring children to the heart of the global TB response, and commit to investing in the ...

Tuberculosis Treatment: Even today, TB remains a major health challenge in our country. While TB can affect any organ in the ...

India has launched the world’s first clinical trial to study Ayurveda alongside standard TB treatment. The trial will assess ...